PTK7 and acute lymphoblastic leukemia: Aptamer Sgc8c-7 specifically targets protein tyrosine kinase 7, which is highly expressed on the membrane of T-ALL cell line CCRF-CEM,62 thus providing excellent possibilities for more effective and precise treatment of ALL.